Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline

被引：1
|
作者：
Giacomucci, Giulia [1 ]
Mazzeo, Salvatore [1 ]
Bagnoli, Silvia [1 ]
Ingannato, Assunta [1 ]
Padiglioni, Sonia [2 ]
Sorbi, Sandro [1 ]
Bessi, Valentina [1 ]
Nacmias, Benedetta [1 ]
机构：
[1] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy
[2] AOU Careggi, Res & Innovat Ctr Dementia CRIDEM, Florence, Italy
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203114
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P7-6.001
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline
    Giacomucci, G.
    Mazzeo, S.
    Bagnoli, S.
    Ingannato, A.
    Padiglioni, S.
    Galdo, G.
    Crucitti, C.
    Emiliani, F.
    Moschini, V.
    Morinelli, C.
    Sorbi, S.
    Bessi, V.
    Nacmias, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 122 - 122
  • [2] Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giacomucci, Giulia
    Mazzeo, Salvatore
    Crucitti, Chiara
    Ingannato, Assunta
    Bagnoli, Silvia
    Padiglioni, Sonia
    Galdo, Giulia
    Emiliani, Filippo
    Frigerio, Daniele
    Moschini, Valentina
    Morinelli, Carmen
    Sorbi, Sandro
    Bessi, Valentina
    Nacmias, Benedetta
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 453
  • [3] A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease
    Tagai, Kenji
    Tatebe, Harutsugu
    Matsuura, Sayo
    Hong, Zhang
    Kokubo, Naomi
    Matsuoka, Kiwamu
    Endo, Hironobu
    Oyama, Asaka
    Hirata, Kosei
    Shinotoh, Hitoshi
    Kataoka, Yuko
    Matsumoto, Hideki
    Oya, Masaki
    Kurose, Shin
    Takahata, Keisuke
    Ichihashi, Masanori
    Kubota, Manabu
    Seki, Chie
    Shimada, Hitoshi
    Takado, Yuhei
    Kawamura, Kazunori
    Zhang, Ming-Rong
    Soeda, Yoshiyuki
    Takashima, Akihiko
    Higuchi, Makoto
    Tokuda, Takahiko
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [4] Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression
    Tsiknia, Amaryllis A.
    Edland, Steven D.
    Sundermann, Erin E.
    Reas, Emilie T.
    Brewer, James B.
    Galasko, Douglas
    Banks, Sarah J.
    MOLECULAR PSYCHIATRY, 2022, 27 (10) : 4314 - 4322
  • [5] Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
    Amaryllis A. Tsiknia
    Steven D. Edland
    Erin E. Sundermann
    Emilie T. Reas
    James B. Brewer
    Douglas Galasko
    Sarah J. Banks
    Molecular Psychiatry, 2022, 27 : 4314 - 4322
  • [6] Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis
    Vacchiano, Veria
    Mastrangelo, Andrea
    Zenesini, Corrado
    Baiardi, Simone
    Avoni, Patrizia
    Polischi, Barbara
    Capellari, Sabina
    Salvi, Fabrizio
    Liguori, Rocco
    Parchi, Piero
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (06): : 428 - 435
  • [7] Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
    Lantero Rodriguez, Juan
    Karikari, Thomas K.
    Suarez-Calvet, Marc
    Troakes, Claire
    King, Andrew
    Emersic, Andreja
    Aarsland, Dag
    Hye, Abdul
    Zetterberg, Henrik
    Blennow, Kaj
    Ashton, Nicholas J.
    ACTA NEUROPATHOLOGICA, 2020, 140 (03) : 267 - 278
  • [8] Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
    Juan Lantero Rodriguez
    Thomas K. Karikari
    Marc Suárez-Calvet
    Claire Troakes
    Andrew King
    Andreja Emersic
    Dag Aarsland
    Abdul Hye
    Henrik Zetterberg
    Kaj Blennow
    Nicholas J. Ashton
    Acta Neuropathologica, 2020, 140 : 267 - 278
  • [9] Plasma p-Tau181 and p-Tau231 in Parkinson's Disease
    Gonzalez, M. C.
    Ashton, N. J.
    Pilitto, A.
    Padovani, A.
    Gomes, B. Fernandes
    Tovar-Rios, D. A.
    Blanc, F.
    Lemstra, A.
    Paquet, C.
    Abdelnour, C.
    Boada, M.
    Bonanni, L.
    Vandenberghe, R.
    Blennow, K.
    Zetterberg, H.
    Aarsland, D.
    MOVEMENT DISORDERS, 2022, 37 : S535 - S536
  • [10] Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
    Janelidze, Shorena
    Stomrud, Erik
    Smith, Ruben
    Palmqvist, Sebastian
    Mattsson, Niklas
    Airey, David C.
    Proctor, Nicholas K.
    Chai, Xiyun
    Shcherbinin, Sergey
    Sims, John R.
    Triana-Baltzer, Gallen
    Theunis, Clara
    Slemmon, Randy
    Mercken, Marc
    Kolb, Hartmuth
    Dage, Jeffrey L.
    Hansson, Oskar
    NATURE COMMUNICATIONS, 2020, 11 (01)
12345